Program details
Intensity-Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer（SAITO YUKOUKAI HOSPITAL）
Radiology Department
SAITO YUKOUKAI HOSPITAL（Kinki/Osaka）
Non-Surgical Treatment for Prostate Cancer
By utilizing the advanced technology of Intensity-Modulated Radiation Therapy (IMRT), we deliver highly precise radiation treatment. This approach minimizes radiation exposure to surrounding healthy organs while administering a high dose to the prostate, achieving treatment outcomes comparable to, or even surpassing, those of surgery.
- Genres
-
- Department
- Disease
- Examination Items/Treatments/Surgical method
- Region/Organ
- Program Summary
- This program provides Intensity-Modulated Radiation Therapy (IMRT) for localized prostate cancer. Regardless of prior examinations at other institutions, MRI and CT scans will be performed at our facility and used for radiation treatment planning. The target area includes the entire prostate and, if necessary, part or all of the seminal vesicles, but the lymph node region is excluded from the radiation field.
The process follows the sequence of consultation → MRI → CT → treatment planning. Once the treatment plan is finalized, radiation therapy begins. The period from consultation to the start of radiation therapy is approximately 10 to 14 days. Radiation is delivered daily on weekdays (excluding weekends and public holidays) for a total of 28 to 29 sessions over about six weeks.
During the treatment period, bowel and bladder control is required, and alcohol consumption is prohibited.
- Medical Institutions
-
SAITO YUKOUKAI HOSPITAL
〒567-0085
Ibaraki City Saito Asagi 7-2-18
Google Map Map
- Examination Items
- Setup Date
- Excluded days
- Required Days/Hours
- Start/end time
- Eligibility Criteria/Exclusions for Treatment
- - No contraindications to radiation therapy, such as complications from collagen diseases (e.g., scleroderma) or hereditary disorders (e.g., xeroderma pigmentosum).
- Must have a trusted urologist in the patient’s home country to ensure follow-up care, including treatment efficacy evaluation and management of side effects after radiation.
- Must be able to stay in Japan for approximately 8 weeks, covering both the preparation and radiation periods, and be available for consultations during that time.
- Outpatient treatment must be feasible (hospitalization is not permitted).
- The patient must personally sign the consent forms for examinations and treatments issued by our clinic, and it is preferable to have an additional family member’s signature.
- No prior history of radiation therapy to the prostate or nearby areas.
- No pacemakers or internal metal implants, allowing for MRI examinations at our clinic.
- Must be able to maintain a supine position without movement for approximately 30 minutes.
- Diagnosed with prostate cancer through pathological examination based on more than 10 prostate biopsies, with a confirmed Gleason's score. The diagnostic report must be provided.
- Prostate imaging diagnosis performed with an MRI of 1.5 Tesla or higher, confirming localized prostate cancer (T-factor of T1-3 in the TNM classification). The imaging data and diagnostic report must be submitted.
- Imaging studies (CT, MRI, bone scintigraphy, FDG-PET/CT) must confirm no lymph node or distant metastasis (N0M0 in the TNM classification). The imaging data and diagnostic report must be submitted.
- Baseline PSA (iPSA) must have been measured, and the test report must be provided.
- It is preferable if hormone therapy (CAB therapy) has been administered for 6 to 12 months before the start of radiation therapy.
- Treatment may be declined if deemed inappropriate for our clinic.
- Precautions / Contraindications
- Radiation therapy cannot be provided if there is a history of prior radiation treatment to the prostate. Hospitalization for treatment is not permitted. Hormone therapy cannot be continued at our clinic during the radiation therapy period.
